UNC Lineberger is recruiting participants for the Vanguard Study, which is evaluating a new type of blood test that screens for several types of cancer. This is the first study of the Cancer Screening Research Network. The post UNC Lineberger launches study to evaluate multi-cancer detection tests appeared first on UNC Lineberger.| UNC Lineberger
UNC Lineberger has launched a first-of-its-kind clinical trial aimed at improving outcomes in BRAF wildtype anaplastic thyroid cancer (ATC). Siddharth Sheth, DO, MPH, and Jeffrey Blumberg, MD, FACS, are leading the trial.| UNC Lineberger
More and more providers are beginning to incorporate the new Practical Geriatric Assessment into their practices.| Medscape
Kwame Kwofie, a citizen of Ghana, found himself in uncharted territory when he faced a head and neck cancer diagnosis thousands of miles away from home.| UNC Lineberger
UNC Lineberger's J. Kaitlin Morrison, PhD, and Carrie Lee, MD, PhD, launched a study to investigate whether UNC Health can successfully conduct hybrid cancer clinical trials across the state.| UNC Lineberger
A new combination of azacitidine, venetoclax, and revumenib demonstrated high rates of complete response and clinical activity in older adults with newly diagnosed acute myeloid leukemia and an NPM1 m...| ascopost.com
Joshua Zeidner, MD, and colleagues report that a combination therapy that adds a recently approved drug to the current standard of care for newly diagnosed acute myeloid leukemia showed high rates of complete remission in an early-phase clinical trial.| UNC Lineberger
With help from your doctor, you can decide how to respond to your diagnosis.| UNC Health Talk
